title: [A case of long-term survivor after combined modality therapy for brain metastasis of bladder carcinoma].
abstract: A 75-year-old man with advanced bladder cancer (cT4N1M0) received three courses of systemic chemotherapy with Methotrexate, Epirubicin and Nedaplatin (MEN). His metastatic lymph node completely disappeared. We performed total cystectomy. Three months after the surgery, he complained of neck pain and nausea. Brain magnetic resonance imaging (MRI) revealed a 3 cm tumor in his right cerebella and a 5 mm tumor in left parietal lobe. He underwent surgical resection of the right cerebellar tumor and a gamma knife therapy for the left parietal tumor. Pathological diagnosis was metastatic urothelial carcinoma. We performed three additional courses of chemotherapy of MEN. He has been well without local recurrence or distant metastasis for 18 months.
authors.affiliation: The Department of Urology and Kidney transplantation, Yokohama City University Medical Center, Japan.
authors.forename: Kengo
authors.initials: K
authors.lastname: Yasuda
authors.forename: Masafumi
authors.initials: M
authors.lastname: Nakamura
authors.forename: Daiji
authors.initials: D
authors.lastname: Takamoto
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Sanjo
authors.forename: Ayako
authors.initials: A
authors.lastname: Gohbara
authors.forename: Jun-ichi
authors.initials: J
authors.lastname: Teranishi
authors.forename: Yasushi
authors.initials: Y
authors.lastname: Yumura
authors.forename: Yasuhide
authors.initials: Y
authors.lastname: Miyoshi
authors.forename: Keiichi
authors.initials: K
authors.lastname: Kondo
authors.forename: Kazumi
authors.initials: K
authors.lastname: Noguchi
authors.forename: Yoshinobu
authors.initials: Y
authors.lastname: Kubota
mesh_terms: D000368:Aged; D001932:Brain Neoplasms / Q000556:secondary*; D002295:Carcinoma, Transitional Cell / Q000473:pathology* / Q000628:therapy*; D003131:Combined Modality Therapy; D006801:Humans; D008297:Male; D017741:Survivors; D001749:Urinary Bladder Neoplasms / Q000473:pathology* / Q000628:therapy*